Resultats globals: 94 registres trobats en 0.03 segons.
Articles, 86 registres trobats
Documents de recerca, 8 registres trobats
Articles 86 registres trobats  1 - 10següentfinal  anar al registre:
1.
24 p, 6.3 MB CD300f immune receptor contributes to healthy aging by regulating inflammaging, metabolism, and cognitive decline / Evans, Frances (Instituto Pasteur de Montevideo) ; Alí-Ruiz, Daniela (Instituto Pasteur de Montevideo) ; Rego, Natalia (Instituto Pasteur de Montevideo) ; Negro-Demontel, Maria Luciana (Instituto Pasteur de Montevideo) ; Lago, Natalia (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Cawen, Fabio Andrés (Instituto Pasteur de Montevideo) ; Pannunzio, Bruno (Instituto Pasteur de Montevideo) ; Sanchez-Molina, Paula (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Reyes, Laura (Centro Uruguayo de Imagenología Molecular) ; Paolino, Andrea (Centro Uruguayo de Imagenología Molecular) ; Rodríguez-Duarte, Jorge (Instituto Pasteur de Montevideo) ; Pérez-Torrado, Valentina (Instituto Pasteur de Montevideo) ; Chicote-González, Almudena (Universitat de Barcelona. Departament de Biomedicina) ; Quijano, Celia (Universidad de la República. Departamento de Bioquímica (Montevideo, Uruguay)) ; Marmisolle, Inés (Universidad de la República. Departamento de Bioquímica (Montevideo, Uruguay)) ; Mulet, Ana Paula (Instituto Pasteur de Montevideo) ; Schlapp, Geraldine (Instituto Pasteur de Montevideo) ; Meikle, Maria Noel (Instituto Pasteur de Montevideo) ; Bresque, Mariana (Instituto Pasteur de Montevideo) ; Crispo, Martina (Instituto Pasteur de Montevideo) ; Savio, Eduardo (Centro Uruguayo de Imagenología Molecular) ; Malagelada, Cristina (Universitat de Barcelona. Departament de Biomedicina) ; Escande, Carlos (Instituto Pasteur de Montevideo) ; Peluffo, Hugo (Instituto Pasteur de Montevideo) ; Universitat Autònoma de Barcelona. Institut de Neurociències
Emerging evidence suggests that immune receptors may participate in many aging-related processes such as energy metabolism, inflammation, and cognitive decline. CD300f, a TREM2-like lipid-sensing immune receptor, is an exceptional receptor as it integrates activating and inhibitory cell-signaling pathways that modulate inflammation, efferocytosis, and microglial metabolic fitness. [...]
2023 - 10.1016/j.celrep.2023.113269
Cell reports, Vol. 42 Núm. 10 (2023) , p. 113269  
2.
135 p, 1.9 MB Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias : An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry / Lewczuk, Piotr (University Hospital of Białystok) ; Riederer, Peter (University Hospital Würzburg) ; O'Bryant, Sid E. (University of North Texas Health Science Center) ; Verbeek, Marcel M. (Radboud Alzheimer center) ; Dubois, Bruno (Salpêtrièrie Hospital) ; Visser, Pieter Jelle (Amsterdam Neuroscience VU University Medical Centre) ; Jellinger, Kurt A. (Institute of Clinical Neurobiology) ; Engelborghs, Sebastiaan (University Hospital Antwerp (Bèlgica)) ; Ramirez, Alfredo (University of Cologne) ; Parnetti, Lucilla (University of Perugia) ; Jack Jr, Clifford R. (Mayo Clinic) ; Teunissen, Charlotte E. (VU University Medical Center Amsterdam) ; Hampel, Harald (heimer (IM2A). Hôpital Pitié-Salpêtrière) ; Lleó, Alberto (Institut d'Investigació Biomèdica Sant Pau) ; Jessen, Frank (German Center for Neurodegenerative Disorders (DZNE)) ; Glodzik, Lidia (NYU Langone Medical Center) ; de Leon, Mony J. (NYU Langone Medical Center) ; Fagan, Anne M. (Washington University School of Medicine) ; Molinuevo, José Luis (Hospital Clínic i Provincial de Barcelona) ; Jansen, Willemijn J. (Maastricht University) ; Winblad, Bengt (Karolinska Institutet (Estocolm, Suècia)) ; Shaw, Leslie M. (University of Pennsylvania) ; Andreasson, Ulf (The Sahlgrenska Academy at the University of Gothenburg) ; Otto, Markus (University of Ulm) ; Mollenhauer, Brit (Kassel and University Medical Center Göttingen) ; Wiltfang, Jens (University of Aveiro) ; Turner, Martin R. (University of Oxford) ; Zerr, Inga (German Center for Neurodegenerative Diseases) ; Handels, Ron (Karolinska Institutet (Estocolm, Suècia)) ; Thompson, Alexander G. (University of Oxford) ; Johansson, Gunilla (Karolinska Institutet (Estocolm, Suècia)) ; Ermann, Natalia (Universitätsklinikum Erlangen. and Friedrich-Alexander Universität Erlangen-Nürnberg) ; Trojanowski, John Q. (University of Pennsylvania) ; Karaca, Ilker (University of Bonn) ; Wagner, Holger (University of Bonn) ; Oeckl, Patrick (University of Ulm) ; van Waalwijk van Doorn, Linda (Radboud Alzheimer center) ; Bjerke, Maria (University of Antwerp) ; Kapogiannis, Dimitrios (National Institute on Aging/National Institutes of Health (NIA/NIH)) ; Kuiperij, H.Bea (Radboud Alzheimer center) ; Farotti, Lucia (University of Perugia) ; Li, Yi (NYU Langone Medical Center) ; Gordon, Brian A. (Washington University School of Medicine) ; Epelbaum, Stéphane (Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A)) ; Vos, Stephanie J.B. (Maastricht University) ; Klijn, Catharina J.M. (Radboud Alzheimer Center) ; Van Nostrand, William E. (Stony Brook University) ; Minguillon, Carolina (Fundació Pasqual Maragall) ; Schmitz, Matthias (University Medical School) ; Gallo, Carla (Universidad Peruana Cayetano Heredia) ; Lopez Mato, Andrea (Maimonides University) ; Thibaut, Florence (University Hospital Cochin-Site Tarnier 89 rue d'Assas) ; Lista, Simone (heimer (IM2A). Hôpital Pitié-Salpêtrière) ; Alcolea, Daniel (Institut d'Investigació Biomèdica Sant Pau) ; Zetterberg, Henrik (UCL Institute of Neurology (Regne Unit)) ; Blennow, Kaj (Sahlgrenska University Hospital (Suècia)) ; Kornhuber, Johannes (Universitätsklinikum Erlangen) ; Universitat Autònoma de Barcelona
In the 12 years since the publication of the first Consensus Paper of the WFSBP on biomarkers of neurodegenerative dementias, enormous advancement has taken place in the field, and the Task Force takes now the opportunity to extend and update the original paper. [...]
2018 - 10.1080/15622975.2017.1375556
World Journal of Biological Psychiatry, Vol. 19 Núm. 4 (19 2018) , p. 244-328  
3.
7 p, 663.7 KB Common and rare TBK1 variants in early-onset Alzheimer disease in a European cohort / Verheijen, Jan (University of Antwerp) ; van der Zee, Julie (University of Antwerp) ; Gijselinck, Ilse (University of Antwerp) ; Van den Bossche, Tobi (University Hospital Antwerp (Bèlgica)) ; Dillen, Lubina (University of Antwerp) ; Heeman, Bavo (University of Antwerp) ; Gómez-Tortosa, Estrella (Hospital Universitario Fundación Jiménez Díaz) ; Lladó, Albert (Hospital Clínic i Provincial de Barcelona) ; Sanchez-Valle, Raquel (Hospital Clínic i Provincial de Barcelona) ; Graff, Caroline (Karolinska University Hospital and Karolinska Institutet (Suecia)) ; Pastor, Pau (Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas) ; Pastor, Maria A. (Clínica Universidad de Navarra) ; Benussi, Luisa (Istituto Centro San Giovanni di Dio-Fatebenefratelli) ; Ghidoni, Roberta (Istituto Centro San Giovanni di Dio-Fatebenefratelli) ; Binetti, Giuliano (Istituto Centro San Giovanni di Dio-Fatebenefratelli) ; Clarimón, Jordi (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ; de Mendonça, Alexandre (University of Lisbon) ; Gelpi, Ellen (Hospital Clínic i Provincial de Barcelona) ; Tsolaki, Magda (Aristotle University of Thessaloniki) ; Diehl-Schmid, Janine (Technische Universität München) ; Nacmias, Benedetta (University of Florence) ; Almeida, Maria Rosário (University of Coimbra) ; Borroni, Barbara (University of Brescia) ; Matej, Radoslav (Thomayer Hospital in Prague) ; Ruiz, Agustín (Fundació ACE) ; Engelborghs, Sebastiaan (University Hospital Antwerp (Bèlgica)) ; Vandenberghe, Rik (University Hospitals Leuven (Bèlgica)) ; De Deyn, Peter P. (University Hospital Antwerp (Bèlgica)) ; Cruts, Marc (University of Antwerp) ; Van Broeckhoven, Christine (University of Antwerp) ; Sleegers, Kristel (University of Antwerp) ; Goeman, Johan ; Nuytten, Dirk ; Vandenbulcke, Mathieu ; Santens, Patrick 700 1_ ; Sieben, Anne ; Dermaut, Bart ; Versijpt, Jan ; Michotte, Alex ; Deryck, Olivier ; Bergmans, Bruno ; Willems, Christiana ; Ivanoiu, Adrian ; Salmon, Eric ; Alexopoulos, Panagiotis (Technische Universität München) ; Sorbi, Sandro ; Bessi, Valentina ; Bagnoli, Silvia ; Santana, Isabel ; Simões do Couto, Frederico ; Martins, Madalena ; Thonberg, Häkan ; Fratiglioni, Laura ; Padovani, Alessandro ; Rohan, Zdenek ; Razquin, Cristina ; Lorenzo, Elena ; Iglesias, Elena ; Seijo-Martínez, Manuel ; Rene, Ramon ; Gascon, Jordi ; Campdelacreu, Jaume ; Koutroumani, Maria ; Lleó, Alberto (Institut d'Investigació Biomèdica Sant Pau) ; Fortea, Juan (Institut d'Investigació Biomèdica Sant Pau) ; Blesa, Rafael (Institut d'Investigació Biomèdica Sant Pau) ; Universitat Autònoma de Barcelona
TANK-binding kinase 1 (TBK1) loss-of-function (LoF) mutations are known to cause frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS), often combined with memory deficits early in the disease course. [...]
2018 - 10.1016/j.neurobiolaging.2017.10.012
Neurobiology of Aging, Vol. 62 (february 2018) , p. 245.e1-245.e7  
4.
11 p, 1.1 MB Atrophy in the thalamus but not cerebellum is specific for C9orf72 FTD and ALS patients - An atlas-based volumetric MRI study / Schönecker, Sonja (Ludwig-Maximilians-Universität) ; Neuhofer, Christiane (Ludwig-Maximilians-Universität) ; Otto, Markus (University of Ulm) ; Ludolph, Albert (University of Ulm) ; Kassubek, Jan (University of Ulm) ; Landwehrmeyer, Bernhard (University of Ulm) ; Anderl-Straub, Sarah (University of Ulm) ; Semler, Elisa (University of Ulm) ; Diehl-Schmid, Janine (Technical University of Munich) ; Prix, Catharina (Ludwig-Maximilians-Universität) ; Vollmar, Christian (Ludwig-Maximilians-Universität) ; Fortea, Juan (Institut d'Investigació Sant Pau) ; Huppertz, Hans-Jürgen (Swiss Epilepsy Clinic) ; Arzberger, Thomas (Ludwig-Maximilians-Universität) ; Edbauer, Dieter (Munich Cluster for Systems Neurology (SyNergy)) ; Feddersen, Berend (Ludwig-Maximilians-Universität) ; Dieterich, Marianne (Munich Cluster for Systems Neurology (SyNergy)) ; Schroeter, Matthias L. (University Hospital Leipzig) ; Volk, Alexander E. (University Medical Center Hamburg-Eppendorf) ; Fließbach, Klaus (University Hospital Bonn (Bonn, Alemanya)) ; Schneider, Anja (University Hospital Bonn (Bonn, Alemanya)) ; Kornhuber, Johannes (Friedrich-Alexander University Erlangen-Nürnberg) ; Maler, Manuel (Friedrich-Alexander University Erlangen-Nürnberg) ; Prudlo, Johannes (German Center for Neurodegenerative Diseases (DZNE)) ; Jahn, Holger (AMEOS Klinikum Heiligenhafen) ; Boeckh-Behrens, Tobias (Technical University of Munich) ; Danek, Adrian (Ludwig-Maximilians-Universität) ; Klopstock, Thomas (Ludwig-Maximilians-Universität) ; Levin, Johannes (German Center for Neurodegenerative Diseases (DZNE)) ; Universitat Autònoma de Barcelona
The neuropathology of patients with frontotemporal dementia (FTD) or amyotrophic lateral sclerosis (ALS) due to a C9orf72 mutation is characterized by two distinct types of characteristic protein depositions containing either TDP-43 or so-called dipeptide repeat proteins that extend beyond frontal and temporal regions. [...]
2018 - 10.3389/fnagi.2018.00045
Frontiers in aging neuroscience, Vol. 10 Núm. FEB (15 2018) , p. 45  
5.
8 p, 667.2 KB Rare nonsynonymous variants in SORT1 are associated with increased risk for frontotemporal dementia / Philtjens, Stéphanie (University of Antwerp) ; Van Mossevelde, Sara (Antwerp University Hospital (UZA)) ; Van der Zee, Julie (University of Antwerp) ; Wauters, Eline (University of Antwerp) ; Dillen, Lubina (University of Antwerp) ; Vandenbulcke, Mathieu (University Hospitals Leuven (Bèlgica)) ; Vandenberghe, Rik (University Hospitals Leuven (Bèlgica)) ; Ivanoiu, Adrian (Université Catholique de Louvain) ; Sieben, Anne (Universitair Ziekenhuis Gent) ; Willems, Christiana (Jessa Hospital) ; Benussi, Luisa (Istituto Centro San Giovanni di Dio-Fatebenefratelli) ; Ghidoni, Roberta (Istituto Centro San Giovanni di Dio-Fatebenefratelli) ; Binetti, Giuliano (Istituto Centro San Giovanni di Dio-Fatebenefratelli) ; Borroni, Barbara (University of Brescia) ; Padovani, Alessandro (University of Brescia) ; Pastor, Pau (Instituto de Salud Carlos III) ; Diez-Fairen, Monica (Instituto de Salud Carlos III) ; Aguilar, Miquel (Instituto de Salud Carlos III) ; de Mendonça, Alexandre (University of Lisbon) ; Miltenberger-Miltényi, Gabriel (University of Lisbon) ; Hernández, Isabel (Universitat Internacional de Catalunya. Institut Català de Neurociències Aplicades) ; Boada, M. (Universitat Internacional de Catalunya. Institut Català de Neurociències Aplicades) ; Ruiz, A. (Universitat Internacional de Catalunya. Institut Català de Neurociències Aplicades) ; Nacmias, B. (University of Florence) ; Sorbi, S. (IRCCS Don Gnocchi) ; Almeida, M.Rosario (University of Coimbra) ; Santana, Isabel (University of Coimbra) ; Clarimón, Jordi (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ; Lleó, Alberto (Institut d'Investigació Biomèdica Sant Pau) ; Frisoni, Giovanni B. (IRCCS Fatebenefratelli) ; Sanchez-Valle, Raquel (Hospital Clínic i Provincial de Barcelona) ; Llado Plarrumani, Albert (Hospital Clínic i Provincial de Barcelona) ; Gómez-Tortosa, Estrella (Hospital Universitario Fundación Jiménez Díaz) ; Gelpi, Ellen (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Van den Broeck, Marleen (University of Antwerp) ; Peeters, Karin (University of Antwerp) ; Cras, Patrick (Antwerp University Hospital (UZA)) ; De Deyn, Peter P. (Middelheim and Hoge Beuken) ; Engelborghs, Sebastiaan (Middelheim and Hoge Beuken) ; Cruts, Marc (University of Antwerp) ; Van Broeckhoven, Christine (University of Antwerp) ; Universitat Autònoma de Barcelona
We investigated the genetic role of sortilin (SORT1) in frontotemporal dementia (FTD). SORT1 is the neuronal receptor for granulin, encoded by the progranulin gene (GRN), a major causal gene for inherited FTD. [...]
2018 - 10.1016/j.neurobiolaging.2018.02.011
Neurobiology of Aging, Vol. 66 (june 2018) , p. 181.e3-181.e10  
6.
12 p, 1.2 MB Plasma biomarkers for amyloid, tau, and cytokines in Down syndrome and sporadic Alzheimer's disease / Startin, Carla M. (LonDownS Consortium (London Down Syndrome Consortium)) ; Ashton, Nicholas J. (University of Gothenburg) ; Hamburg, Sarah (LonDownS Consortium (London Down Syndrome Consortium)) ; Hithersay, Rosalyn (LonDownS Consortium (London Down Syndrome Consortium)) ; Wiseman, Frances K. (University College London) ; Mok, Kin Y. (Hong Kong University of Science and Technology) ; Hardy, John (University College London) ; Lleó, Alberto (Institut d'Investigació Biomèdica Sant Pau) ; Lovestone, Simon (University of Oxford) ; Parnetti, Lucilla (University of Perugia) ; Zetterberg, Henrik (UCL Institute of Neurology (Regne Unit)) ; Hye, Abdul (Maudsley NHS Foundation) ; Fisher, Elisabeth ; Nizetic, Dean ; Tybulewicz, Victor ; Karmiloff-Smith, Anette ; Al-Janabi, Tamara ; Zhang, David ; Strydom, André (LonDownS Consortium (London Down Syndrome Consortium)) ; Universitat Autònoma de Barcelona
Down syndrome (DS), caused by chromosome 21 trisomy, is associated with an ultra-high risk of dementia due to Alzheimer's disease (AD), driven by amyloid precursor protein (APP) gene triplication. Understanding relevant molecular differences between those with DS, those with sporadic AD (sAD) without DS, and controls will aid in understanding AD development in DS. [...]
2019 - 10.1186/s13195-019-0477-0
Alzheimer's research & therapy, Vol. 11 Núm. 1 (21 2019) , p. 26  
7.
22 p, 986.7 KB Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort / Kim, M. (Steno Diabetes Center Copenhagen) ; Snowden, S. (University of Cambridge) ; Suvitaival, T. (Steno Diabetes Center Copenhagen) ; Ali, A. (Steno Diabetes Center Copenhagen) ; Merkler, D.J. (University of South Florida) ; Ahmad, T. (King's College London) ; Westwood, S. (University of Oxford) ; Baird, A. (University of Oxford) ; Proitsi, P. (King's College London) ; Nevado-Holgado, Alejo (University of Oxford) ; Hye, A. (Steno Diabetes Center Copenhagen) ; Bos, I. (Maastricht University) ; Vos, S. (Maastricht University) ; Vandenberghe, R. (University Hospitals Leuven (Bèlgica)) ; Teunissen, C. (Amsterdam Neuroscience) ; ten Kate, M. (Amsterdam Neuroscience) ; Scheltens, P. (Amsterdam UMC. University Medical Center) ; Gabel, Silvy (KU Leuven) ; Meersmans, K. (KU Leuven) ; Blin, Olivier ; Richardson, J. (GlaxoSmithKline R&D) ; De Roeck, E. (University of Antwerp) ; Sleegers, Kristel (VIB) ; Bordet, Régis (University of Lille) ; Rami Gonzalez, Lorena (Hospital Clínic i Provincial de Barcelona) ; Kettunen, P. (John Radcliffe Hospital (Oxford, Regne Unit)) ; Tsolaki, Magda (AHEPA University Hospital (Grècia)) ; Verhey, F. (Maastricht University) ; Sala, Isabel (Institut d'Investigació Biomèdica Sant Pau) ; Lleó, Alberto (Institut d'Investigació Biomèdica Sant Pau) ; Peyratout, G. (Lausanne University Hospital) ; Tainta, M. (CITA-Alzheimer Foundation) ; Johannsen, P. (Copenhagen University Hospital) ; Freund-Levi, Yvonne (Karolinska University Hospital and Karolinska Institutet (Suecia)) ; Frölich, L. (University of Heidelberg) ; Dobricic, V. (University of Lübeck) ; Engelborghs, Sebastiaan (University Hospital Antwerp (Bèlgica)) ; Frisoni, Giovanni B. (University of Geneva) ; Molinuevo, José Luis (Hospital Clínic i Provincial de Barcelona) ; Wallin, Anders (University of Gothenburg) ; Popp, J. (Geneva University Hospitals) ; Martinez-Lage, P. (CITA-Alzheimer Foundation) ; Bertram, Lars (University of Lübeck) ; Barkhof, Frederik (Amsterdam Neuroscience) ; Ashton, Nicholas J (University of Gothenburg) ; Blennow, Kaj (Sahlgrenska University Hospital (Suècia)) ; Zetterberg, H. (UK Dementia Research Institute) ; Streffer, J. (Janssen Pharmaceutical Companies) ; Visser, P.J. (Amsterdam Neuroscience) ; Lovestone, S. (University of Oxford) ; Legido-Quigley, C. (Steno Diabetes Center Copenhagen) ; Universitat Autònoma de Barcelona
A critical and as-yet unmet need in Alzheimer's disease (AD) is the discovery of peripheral small molecule biomarkers. Given that brain pathology precedes clinical symptom onset, we set out to test whether metabolites in blood associated with pathology as indexed by cerebrospinal fluid (CSF) AD biomarkers. [...]
2019 - 10.1016/j.jalz.2019.03.004
Alzheimer's & Dementia, Vol. 15 Núm. 6 (june 2019) , p. 817-827  
8.
18 p, 851.1 KB Clinical outcome measures in dementia with Lewy bodies trials : critique and recommendations / Rodriguez-Porcel, Federico (Medical University of South Carolina) ; Wyman-Chick, Kathryn A. (HealthPartners) ; Abdelnour, Carla (Universitat Autònoma de Barcelona) ; Toledo, Jon B. (University of Florida) ; Ferreira, Daniel (Mayo Clinic) ; Urwyler, Prabitha (University of Bern) ; Weil, Rimona S. (University College London) ; Kane, Joseph (Queen's University) ; Pilotto, Andrea (University of Brescia) ; Rongve, Arvid (The University of Bergen) ; Boeve, Bradley (Mayo Clinic) ; Taylor, John-Paul (Newcastle University) ; McKeith, Ian (Newcastle University) ; Aarsland, Dag (King's College London) ; Lewis, Simon J. G. (University of Sydney)
The selection of appropriate outcome measures is fundamental to the design of any successful clinical trial. Although dementia with Lewy bodies (DLB) is one of the most common neurodegenerative conditions, assessment of therapeutic benefit in clinical trials often relies on tools developed for other conditions, such as Alzheimer's or Parkinson's disease. [...]
2022 - 10.1186/s40035-022-00299-w
Translational Neurodegeneration, Vol. 11 (may 2022)  
9.
1 p, 574.4 KB Correction : Clinical outcome measures in dementia with Lewy bodies trials: critique and recommendations / Rodriguez-Porcel, Federico (Medical University of South Carolina) ; Wyman-Chick, Kathryn A. (HealthPartners) ; Abdelnour, Carla (Universitat Autònoma de Barcelona) ; Toledo, Jon B. (University of Florida) ; Ferreira, Daniel (Mayo Clinic) ; Urwyler, Prabitha (University of Bern) ; Weil, Rimona S. (University College London) ; Kane, Joseph (Queen's University) ; Pilotto, Andrea (University of Brescia) ; Rongve, Arvid (The University of Bergen) ; Boeve, Bradley (Mayo Clinic) ; Taylor, John-Paul (Newcastle University) ; McKeith, Ian (Newcastle University) ; Aarsland, Dag (King's College London) ; Lewis, Simon J. G. (University of Sydney)
The selection of appropriate outcome measures is fundamental to the design of any successful clinical trial. Although dementia with Lewy bodies (DLB) is one of the most common neurodegenerative conditions, assessment of therapeutic benefit in clinical trials often relies on tools developed for other conditions, such as Alzheimer's or Parkinson's disease. [...]
2022 - 10.1186/s40035-022-00306-0
Translational Neurodegeneration, Vol. 11 (may 2022)  
10.
11 p, 2.6 MB Metabolic Correlates of Dopaminergic Loss in Dementia with Lewy Bodies / Huber, M. (LMU Munich) ; Beyer, L. (LMU Munich) ; Prix, C. (LMU Munich) ; Schönecker, S. (LMU Munich) ; Palleis, C. (LMU Munich) ; Rauchmann, B.S. (LMU Munich) ; Morbelli, S. (University of Genoa) ; Chincarini, A. (Genoa section) ; Bruffaerts, R. (University Hospitals Leuven (Bèlgica)) ; Vandenberghe, R. (University Hospitals Leuven (Bèlgica)) ; Van Laere, K. (University Hospitals Leuven (Bèlgica)) ; Kramberger, M.G. (University Medical Centre) ; Trost, M. (University Medical Centre) ; Grmek, M. (University Medical Centre) ; Garibotto, V. (Geneva University) ; Nicastro, N. (University of Cambridge) ; Frisoni, Giovanni B. (Geneva University Hospitals) ; Lemstra, A.W. (VU Medical Center Alzheimer Center) ; van der Zande, J. (VU Medical Center Alzheimer Center) ; Pilotto, A. (Isidoro Hospital) ; Padovani, A. (University of Brescia) ; Garcia-Ptacek, S. (Internal Medicine) ; Savitcheva, I. (Karolinska University Hospital and Karolinska Institutet (Suecia)) ; Ochoa-Figueroa, M.A. (Linköping University) ; Davidsson, A. (Linköping University Hospital) ; Camacho, Valle (Institut d'Investigació Biomèdica Sant Pau) ; Peira, E. (University of Genoa) ; Arnaldi, D. (University of Genoa) ; Bauckneht, M. (University of Genoa) ; Pardini, M. (Clinical Neurology. Department of Neuroscience (DINOGMI). University of Genoa) ; Sambuceti, G. (University of Genoa) ; Vöglein, J. (DZNE-German Center for Neurodegenerative Diseases) ; Schnabel, J. (LMU Munich) ; Unterrainer, M. (LMU Munich) ; Perneczky, R. (University of Munich) ; Pogarell, O. (LMU Munich) ; Buerger, K. (University of Munich) ; Catak, C. (University of Munich) ; Bartenstein, P. (Munich Cluster for Systems Neurology (SyNergy)) ; Cumming, P. (Queensland University of Technology) ; Ewers, Michael (DZNE-German Center for Neurodegenerative Diseases) ; Danek, Adrian (Ludwig-Maximilians-Universität) ; Levin, J. (Munich Cluster for Systems Neurology (SyNergy)) ; Aarsland, Dag (King's College London) ; Nobili, F. (University of Genoa) ; Rominger, A. (University of Bern) ; Brendel, M. (Munich Cluster for Systems Neurology (SyNergy)) ; Universitat Autònoma de Barcelona
Striatal dopamine deficiency and metabolic changes are well-known phenomena in dementia with Lewy bodies and can be quantified in vivo by I-Ioflupane brain single-photon emission computed tomography of dopamine transporter and F-fluorodesoxyglucose PET. [...]
2020 - 10.1002/mds.27945
Movement Disorders, Vol. 35 Núm. 4 (january 2020) , p. 595-605  

Articles : 86 registres trobats   1 - 10següentfinal  anar al registre:
Documents de recerca 8 registres trobats  
1.
183 p, 2.0 MB Early diagnosis of Alzheimer' Disease in different cultural backgrounds : Electrophysiological and cognitive biomarkers / Chino, Brenda ; Bruña, Ricardo, dir. ; Giménez Llort, Lydia, dir. ; Maestú Unturbe, Fernando, dir.
L'envelliment és un procés natural que es caracteritza per l'acumulació progressiva de canvis fisiològics i per enlentir alguns dominis cognitius. Tot i això, alguns aspectes d'aquests canvis cognitius també s'associen a estats patològics, com la malaltia d'Alzheimer (MA). [...]
El envejecimiento es un proceso natural que se caracteriza por la acumulación progresiva de cambios fisiológicos y la ralentización de algunos dominios cognitivos. Sin embargo, algunos aspectos de estos cambios cognitivos también se asocian a estados patológicos, como la enfermedad de Alzheimer (EA). [...]
Aging is a natural process characterized by the progressive accumulation of physiological changes and a slowdown of some cognitive domains. However, some aspects of these cognitive changes are also associated with pathological states, such as the Alzheimer's disease (AD). [...]

2023  
2.
3.0 MB Early detection of distinctive features of Alzheimer's Disease and other dementias in population with Mild Cognitive Impairment and associated Neuropsychiatric Symptoms / Roberto Herrero, Natalia ; Portella Moll, Maria J., 1975-, dir. ; Valero, Sergi, dir. ; Pérez Solà, Víctor, dir.
L'envelliment produeix canvis biològics al cervell que afecten la memòria, l'atenció i altres funcions cognitives, les quals poden repercutir en el funcionament del dia a dia. El procés normal d'envelliment comporta canvis en la cognició, però una part de la població pateix alteracions que impliquen un deteriorament cognitiu superior a l'esperable respecte la població de referència. [...]
El envejecimiento produce cambios biológicos en el cerebro que afectan a la memoria, la atención y otras funciones cognitivas, las cuales pueden repercutir en el funcionamiento del día a día. El proceso normal de envejecimiento comporta cambios en la cognición, aunque una parte de la población sufre alteraciones que implican un deterioro cognitivo superior al esperable respecto a la población de referencia. [...]
Aging produces biological changes in the brain that affect memory, attention and other cognitive functions, which can have an impact on day-to-day functioning. The normal aging process involves changes in cognition, but part of the population suffers alterations that imply a cognitive deterioration higher than expected with respect to the reference population. [...]

2022  
3.
93 p, 5.1 MB Mixed neurodegenerative dementia : the coexistence of dementia with Lewy bodies and Alzheimer's disease. Expanding our knowledge about the interaction of brain proteinopathies / Abdelnour, Carla ; Pagonabarraga Mora, Javier, dir. ; Aarsland, Dag, dir. ; Kulisevsky, Jaime, dir.
La demència amb cossos de Lewy (DCL) és la segona causa més freqüent de demència neurodegenerativa, i un alt percentatge de casos mostra copatologia amb la malaltia d'Alzheimer (EA). Els pacients amb DCL i EA concomitant tenen un major risc d'ingrés en residència, menor tassa de supervivència i progressió més ràpida a la demència. [...]
La demencia con cuerpos de Lewy (DCL) es la segunda causa más frecuente de demencia neurodegenerativa, y un alto porcentaje de casos muestra copatología con la enfermedad de Alzheimer (EA). Los pacientes con DCL y EA concomitante tienen un mayor riesgo de ingreso en residencia, menor tasa de supervivencia y progresión más rápida a la demencia. [...]
Dementia with Lewy bodies (DLB) is the second most common cause of neurodegenerative dementia, and a high percentage of cases show Alzheimer's disease (AD) copathology. Patients with DLB and concomitant AD have increased risk of nursing home admission, shorter survival rates, and faster progression to dementia. [...]

2022  
4.
81 p, 1.4 MB Estimulación multisensorial en pacientes con demencia institucionalizados : valoración del efecto sobre los trastornos de la conducta / Sánchez Pérez, Manuel ; Tobeña, Adolf, 1950-, dir. ; Pomarol-Clotet, Edith, dir. ; Bulbena Vilarrasa, Antonio, dir.
Les demències constitueixen un grup de malalties d'origen multicausal, principalment associades a l'envelliment com a principal factor de risc. Les demències presenten en algun moment de la seva evolució trastorns psicològics i de comportament, com les al·lucinacions, deliris, l'agitació o la conducta agressiva que és motiu freqüent de consulta mèdica. [...]
Las demencias constituyen un grupo de enfermedades de origen multicausal, principalmente asociadas al envejecimiento como principal factor de riesgo. Las demencias presentan en algún momento de su evolución trastornos psicológicos y del comportamiento, como las alucinaciones, delirios, la agitación o la conducta agresiva que es motivo frecuente de consulta médica. [...]
Dementias constitute a group of diseases of multicausal origin, mainly associated with aging as the main risk factor. At some point in their evolution, dementias present psychological and behavioral disorders, such as hallucinations, delusions, agitation or aggressive behavior, which is a frequent reason for medical consultation. [...]

2021  
5.
112 p, 1.0 MB Marcadores ultrasonográficos asociados a deterioro cognitivo leve y demencia / Crespo Cuevas, Ane Miren ; Vilas Rolán, Dolores, dir. ; López-Cancio Martínez, Elena, dir. ; Dávalos, Antoni, dir.
El deteriorament cognitiu és una de les principals causes de morbimortalitat a nivell mundial. Al voltant de 50 milions de persones a tot el món pateixen demència i es preveu que aquest nombre es tripliqui en 2050. [...]
El deterioro cognitivo es una de las principales causas de morbimortalidad a nivel mundial. Alrededor de 50 millones de personas en todo el mundo padecen demencia y se prevé que este número se triplique en 2050. [...]
Cognitive impairment is one of the main causes of morbidity and mortality in the world. Around 50 million people worldwide have dementia and this number is expected to triple in 2050. In most cases, the aetiology of dementia is still unknown. [...]

2021  
6.
307 p, 16.1 MB Multimodal biomarkers studies in the continuum dementia with lewy bodies - alzheimer's disease / Morenas-Rodríguez, Estrella ; Lleó Bisa, Alberto, dir. ; Fortea, Juan, dir. ; Universitat Autònoma de Barcelona. Institut de Neurociències
La demència amb cossos de Lewy (DCLw) es caracteritza per la seva heterogeneïtat. En aquesta tesi, el meu objectiu és investigar aquesta heterogeneïtat a través de l'anàlisi dels diferents subtipus clínics basats tant en les característiques de presentació predominants en la fase prodròmica de la malaltia com en la diversitat dels trastorns de la son presents, centrant-me en el trastorn del comportament de la son REM (TCSR). [...]
Una de las características principales de la demencia con cuerpos de Lewy (DCLw) es su heterogeneidad. En esta tesis, mi objetivo es investigar esta heterogeneidad a través del análisis de los diferentes subtipos clínicos basados tanto en las características predominantes durante la fase prodrómica de la enfermedad como en la diversidad de los trastornos del sueño presentes en la enfermedad, centrándome en el trastorno del comportamiento del sueño REM (TCSR). [...]
Dementia with Lewy bodies (DLB) is characterized by its heterogeneity. In this thesis, I aim to investigate this clinical heterogeneity through the analysis of the different clinical subtypes based both on the predominant presentation features at the prodromal phase of the disease and by the assessment of sleep disorders, focusing on REM sleep behaviour disorder (RBD). [...]

2020  
7.
1 p, 500.7 KB New therapeutic strategies for alzheimer's disease : new treatments against beta-amyloid and tau-protein / Puga Sánchez, Andrea ; Universitat Autònoma de Barcelona. Facultat de Biociències
2018
Grau en Microbiologia [816]  
8.
32 p, 461.8 KB Sex-related differences in the clinical diagnosis of frontotemporal dementia / Llorca-Bofí, Vicent ; Blesa, Rafael, dir. ; Illán-Gala, Ignacio, dir. ; Universitat Autònoma de Barcelona. Facultat de Medicina
1. Objective: To investigate the sex-related differences in the clinical diagnosis of the frontotemporal dementia (FTD) in the Hospital Sant Pau, Barcelona. 2. Methods: We selected patients diagnosed of FTD from the SPIN cohort (Hospital Sant Pau) and analyzed clinical data. [...]
1. Objetivo: Investigar las diferencias relacionadas con el sexo en el diagnóstico clínico de la demencia frontotemporal (DFT) en el Hospital Sant Pau, Barcelona. 2. Material y método: Se seleccionaron pacientes con diagnóstico de DFT de la cohorte SPIN (Hospital Sant Pau) y se analizaron los datos clínicos. [...]
1. Objectiu: Investigar les diferències relacionades amb el sexe en el diagnòstic clínic de la demència frontotemporal (DFT) a l'Hospital Sant Pau, Barcelona. 2. Material i mètode: Es van seleccionar pacients amb diagnòstic de DFT de la cohort SPIN (Hospital Sant Pau) i es van analitzar les dades clíniques. [...]

2018
Grau en Medicina [1192] - 10.1101/19005702  

Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.